Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|12|4|316-322
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.12, Iss.4, 2012-12, pp. : 316-322
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inflammatory Bowel Disease in the Elderly
Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. :
Macrophages in Inflammatory Bowel Disease
Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. :
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
Costs of Inflammatory Bowel Disease in Germany
By Stark Renee
PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. :